LMAT · Lemaitre Vascular Inc · Webcasts, Transcripts & Audio
$78.29
+0.64 (+0.82%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.79B
Shares
22.88M
Volume · Nov 13
200.09K
Avg daily vol (3M)
288.13K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Lemaitre Vascular Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Lemaitre Vascular Inc (LMAT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-04
Lemaitre Vascular Inc (LMAT) Q3 2026 Earnings Call Transcript
Revenue
$67.97M
▲ 11.3% YoY Diluted EPS
$0.65
▼ 13.3% YoY Gross margin
71.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-22
Lemaitre Vascular Inc (LMAT) September 22, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-08-11
Lemaitre Vascular Inc (LMAT) August 11, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-04
Lemaitre Vascular Inc (LMAT) Q2 2026 Earnings Call Transcript
Positive tone
Sales force and commercial infrastructure buildout
Artograph growth and expansion
Catheters comparison and recall overhang
Revenue
$70.38M
▲ 9.6% YoY Diluted EPS
$0.74
▲ 23.3% YoY Gross margin
72.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-05-14
Lemaitre Vascular Inc (LMAT) May 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Lemaitre Vascular Inc (LMAT) Q1 2026 Earnings Call Transcript
Confident tone
Geographic expansion and going direct
Distribution / export business lumpiness
Financial performance and margin expansion
Revenue
$66.55M
▲ 11.2% YoY Diluted EPS
$0.68
▲ 41.7% YoY Gross margin
72.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-16
Lemaitre Vascular Inc (LMAT) April 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-11
Lemaitre Vascular Inc (LMAT) March 11, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-10
Lemaitre Vascular Inc (LMAT) March 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-25
Lemaitre Vascular Inc (LMAT) Q4 2025 Earnings Call Transcript
Confident tone
Operating Leverage and Margin Expansion
Pricing Power
Chicago to Burlington Manufacturing Consolidation
Revenue
$64.45M*
▲ 15.7% YoY Gross margin
71.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2025-12-04
Lemaitre Vascular Inc (LMAT) December 4, 2025 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2025-11-19
Lemaitre Vascular Inc (LMAT) November 19, 2025 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-06
Lemaitre Vascular Inc (LMAT) Q3 2025 Earnings Call Transcript
Confident tone
Gross margin and operating leverage
Artegraft and RestoreFlow international expansion
Guidance and outlook
Revenue
$61.05M
▲ 11.4% YoY Diluted EPS
$0.75
▲ 53.1% YoY Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Lemaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Transcript
Confident tone
Artegraft international launch
RestoreFlow allograft expansion
Guidance raise and financial performance
Revenue
$64.23M
▲ 15% YoY Diluted EPS
$0.60
▲ 15.4% YoY Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Lemaitre Vascular Inc (LMAT) Q1 2025 Earnings Call Transcript
Revenue
$59.87M
▲ 12% YoY Diluted EPS
$0.48
▲ 9.1% YoY Gross margin
69.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Lemaitre Vascular Inc (LMAT) Q4 2024 Earnings Call Transcript
Confident tone
Product portfolio performance
Regulatory / MDR CE Mark progress
Sales force expansion
Revenue
$55.72M*
▲ 14% YoY Gross margin
69.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Lemaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Transcript
Confident tone
Margin and profitability
Top-line growth and pricing
Allograft international expansion
Revenue
$54.82M
▲ 15.6% YoY Diluted EPS
$0.49
▲ 48.5% YoY Gross margin
67.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Lemaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Transcript
Confident tone
MDR CE Mark Regulatory Progress
ERP Implementation
Gross Margin Expansion
Revenue
$55.85M
▲ 11.4% YoY Diluted EPS
$0.52
▲ 44.4% YoY Gross margin
68.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Lemaitre Vascular Inc (LMAT) Q1 2024 Earnings Call Transcript
Confident tone
ODR mix shift strategy
Strategic acquisitions / M&A pipeline
Vertical market demand
Revenue
$53.48M
▲ 13.6% YoY Diluted EPS
$0.44
▲ 63% YoY Gross margin
68.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Lemaitre Vascular Inc (LMAT) Q4 2023 Earnings Call Transcript
Confident tone
Gross Margin Expansion and Manufacturing
Artegraft Acquisition Integration and International Filings
Sales Force Expansion and Territory Reorganization
Revenue
$48.88M
▲ 19.4% YoY Diluted EPS
$0.38
▲ 52% YoY Gross margin
68.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Lemaitre Vascular Inc (LMAT) Q3 2023 Earnings Call Transcript
Revenue
$47.41M
▲ 21.5% YoY Diluted EPS
$0.33
▲ 32% YoY Gross margin
65.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Lemaitre Vascular Inc (LMAT) Q2 2023 Earnings Call Transcript
Revenue
$50.12M
▲ 28.4% YoY Diluted EPS
$0.36
▲ 125% YoY Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Lemaitre Vascular Inc (LMAT) Q1 2023 Earnings Call Transcript
Revenue
$47.08M
▲ 19% YoY Diluted EPS
$0.27
▲ 0% YoY Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Lemaitre Vascular Inc (LMAT) Q4 2022 Earnings Call Transcript
Revenue
$40.95M
▲ 3.7% YoY Diluted EPS
$0.25
▼ 10.7% YoY Gross margin
63.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Lemaitre Vascular Inc (LMAT) Q3 2022 Earnings Call Transcript
Revenue
$39.03M
▲ 1.7% YoY Diluted EPS
$0.25
▼ 16.7% YoY Gross margin
64.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Lemaitre Vascular Inc (LMAT) Q2 2022 Earnings Call Transcript
Revenue
$39.03M
▼ 4% YoY Diluted EPS
$0.16
▼ 60% YoY Gross margin
71.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Lemaitre Vascular Inc (LMAT) Q1 2022 Earnings Call Transcript
Revenue
$39.56M
▲ 10.2% YoY Diluted EPS
$0.27
▼ 3.6% YoY Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Lemaitre Vascular Inc (LMAT) Q4 2021 Earnings Call Transcript
Revenue
$39.50M
▲ 5.2% YoY Diluted EPS
$0.28
▼ 17.6% YoY Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Lemaitre Vascular Inc (LMAT) Q3 2021 Earnings Call Transcript
Revenue
$38.37M
▲ 5.4% YoY Diluted EPS
$0.30
▼ 18.9% YoY Gross margin
64.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-13
Lemaitre Vascular Inc (LMAT) Q2 2021 Earnings Call Transcript
Revenue
$40.67M
▲ 63.7% YoY Diluted EPS
$0.40
▲ 135.3% YoY Gross margin
65.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Lemaitre Vascular Inc (LMAT) Q1 2021 Earnings Call Transcript
Revenue
$35.88M
▲ 17.5% YoY Diluted EPS
$0.28
▲ 75% YoY Gross margin
66.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Lemaitre Vascular Inc (LMAT) Q4 2020 Earnings Call Transcript
Revenue
$37.55M
▲ 24.5% YoY Diluted EPS
$0.34
▲ 47.8% YoY Gross margin
65.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Lemaitre Vascular Inc (LMAT) Q3 2020 Earnings Call Transcript
Revenue
$36.42M
▲ 25.1% YoY Diluted EPS
$0.37
▲ 48% YoY Gross margin
62.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Lemaitre Vascular Inc (LMAT) Q2 2020 Earnings Call Transcript
Revenue
$24.85M
▼ 15.7% YoY Diluted EPS
$0.17
▼ 26.1% YoY Gross margin
68.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Lemaitre Vascular Inc (LMAT) Q1 2020 Earnings Call Transcript
Revenue
$30.55M
▲ 7.3% YoY Diluted EPS
$0.16
▼ 5.9% YoY Gross margin
67.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-06
Lemaitre Vascular Inc (LMAT) Q4 2019 Earnings Call
Revenue
$30.17M
▲ 6.3% YoY Diluted EPS
$0.23
▼ 23.3% YoY Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–36 of 36 webcasts
Key facts
CIK
1158895
CUSIP
525558201
13F (30d)
255 filings
226 filers
Visit website
Investor relations